Melanoma Therapeutics Foundation
About Us What is Melanoma? Drug Development Process Patient Information Join Us Contact Us

Welcome to the Melanoma Gateway
View current clinical trials in which you may be qualified to participate.

Clinical Trials Scan Clinical Trials Scan

Melanoma Patient Forum Melanoma Patient Forum

 

The Melanoma Therapeutics Foundation: Supporting new approaches to Melanoma Treatment

MTF is the only foundation solely focused on advancing therapeutics for melanoma. The MTF is committed to:

  1. Developing resources for patients, their families and physicians

  2. Providing support for research directed at bringing new therapeutics to clinical trials for melanoma, and

  3. Promoting drug development through building relationships with
    pharmaceutical and biotechnology companies.
 
Ellis Family Statement on the
Passing of Harold A. "Hal" Ellis, Jr.

January 8, 2009

 

With great sadness, the Ellis family announces the passing of Harold A. "Hal" Ellis, Jr., Co-Founder of Grubb & Ellis Company, Chairman of Ellis Partners LLC, Founder and Chairman of the Melanoma Therapeutics Foundation.

Hal's professional achievements stand on their own. He was an innovator, a true visionary in all that he did. He continually reinvented himself and in doing so, changed the way business was done. When diagnosed with Melanoma six years ago, Hal applied this same energy to the challenge of establishing a foundation that both helps patients understand their treatment options, but also helps researchers, clinicians and physicians work more collaboratively towards developing a cure for Melanoma. His absence will be keenly felt by both his family and his community.

In lieu of flowers, the family requests that Hal's legacy be recognized through donations to The Melanoma Therapeutics Foundation, 111 Sutter Street, Suite 800, San Francisco, CA 94104 or by using the link below.

 

Your Donation Helps
DonateNow

Melanoma Therapeutics Foundation
Copyright © 2008